"Do-it-yourself" blood pressure measurements and medicine changes work better than usual doctor-office care in some patients, a study of older adults in England found.
Scientists have identified chemical changes in the DNA of patients with Crohn’s disease that...
For the 2.2 million Americans battling glaucoma, the main course of action for staving off...
To date, almost all studies of autism in children have used a single imaging technique to...
Researchers have developed a way to use a laser to measure people's blood sugar, and, with more work to shrink the laser system to a portable size, the technique could allow diabetics to check their condition without pricking themselves to draw blood.
A newborn screening test for severe combined immunodeficiency (SCID) reliably identifies infants with this life-threatening inherited condition, leading to prompt treatment and high survival rates, according to a new study.
Children with sensory processing disorder (SPD) have decreased white matter brain connections in sensory regions very different from those with autism, say researchers. Their study is the first to compare, and find critical differences in, brain connectivity in autism versus SPD versus controls.
Oncologists are melding magnetic resonance imaging (MRI) technology with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable.
A nasal brush test can rapidly and accurately diagnose Creutzfeldt-Jakob disease (CJD), an incurable and ultimately fatal neurodegenerative disorder, according to a new study.
In the largest study of its kind, researchers suggests that in older people, not getting enough vitamin D may double the risk of developing dementia and Alzheimer’s disease.
A team of scientists has developed an entirely non-invasive technique that provides a view of blood flow in the brain. The tool could provide powerful insights into strokes and possibly Alzheimer's disease.
The Food and Drug Administration says it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.
Researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that could give doctors a simple blood test to reliably predict a person’s risk of attempting suicide.
Scientists have linked more than 100 spots in our DNA to the risk of developing schizophrenia, casting light on the mystery of what makes the disease tick. Such work could eventually point to new treatments, although they are many years away.
Scientists have linked a new protein to Alzheimer's disease, different from the amyloid and tau that make up the sticky brain plaques and tangles long known to be its hallmarks.
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Located deep in the human gut, the small intestine is not easy to examine. Now, researchers are developing a new imaging technique involving nanoparticles suspended in liquid to form “nanojuice” that patients would drink.
3-D mammograms may be better at finding cancer than regular scans, a large study suggests, although whether that means saving more lives isn't known. The study involved almost half a million breast scans, with more than one-third of them using relatively new 3-D imaging along with conventional scans.
Stanford University researchers have devised a noninvasive way to detect heart-transplant rejection weeks or months earlier than previously possible. The test, which relies on the detection of increasing amounts of the donor’s DNA in the blood of the recipient, does not require the removal of any heart tissue.
Lung cancer causes more deaths in the U.S. than the next three most common cancers combined. The reason for the striking mortality rate is simple: poor detection. Lung cancer attacks without leaving any fingerprints, quietly afflicting its victims and metastasizing uncontrollably—to the point of no return. Now a new device may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.
Improved diagnosis and management of one of the most common cancers in men- prostate cancer- could result from research, which has discovered that seminal fluid (semen) contains biomarkers for the disease.
A test that counts the number of locations in tumor specimens where tumor cells may invade blood vessels predicted the risk of distant spread, or metastasis, for the most common type of breast cancer.
Christofer Toumazou believes he can change the world with his “one chip, one bug – one chip, one drug,” slogan. Nominated for the European Patent Office’s 2014 European Inventor award, he holds a patent for the technology behind a microchip that can analyze DNA within 30 minutes and without a laboratory.
A sensor which can be used to screen for diabetes in resource-poor settings has been developed by researchers and tested in diabetic patients, and will soon be field tested in sub-Saharan Africa.
A multicenter team of researchers report that a commercial test designed to rule out the presence of genetic biomarkers of prostate cancer may be accurate enough to exclude the need for repeat prostate biopsies in many— if not most— men.
Scientists and physicians at UC San Francisco are leading a $26 million, multi-institutional research program in which they will employ advanced technology to characterize human brain networks and better understand and treat a range of common, debilitating psychiatric disorders.
Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer’s disease or the normal aging process.
Researchers from The University of Texas at Dallas and the University of Tokyo have created electronic devices that become soft when implanted inside the body and can deploy to grip 3-D objects, such as large tissues, nerves and blood vessels. These biologically adaptive, flexible transistors might one day help doctors learn more about what is happening inside the body, and stimulate the body for treatments.
An app called DermoScreen, which would allow users to take a photo of a suspicious mole or lesion with your phone, run it through an embedded software program and find out within a few seconds if it is likely to be cancerous, is currently being evaluated for further testing.
- Page 1